Stress induced disturbances of the HPA axis: A pathway to type 2 diabetes?

Medical Science Monitor

Volumn 9, Issue 2, 2003, Pages

  Rosmond, Roland ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cortisol; Diabetes; Environment; Genes; Insulin; Resistance; Visceral obesity

Indexed keywords

HYDROCORTISONE;

FEEDBACK SYSTEM; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RELEASE; INSULIN RESISTANCE; LONG TERM EXPOSURE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; STIMULUS RESPONSE;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OBESITY; PITUITARY-ADRENAL SYSTEM; STRESS;

EID: 0037298441     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. King H, Aubert R, Herman W: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 1998; 21: 1414-1431
2. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 1994; 43: 1066-84
3. Sacks DB, McDonald JM. The pathogenesis of type II diabetes mellitus. A polygenic disease. Am J Clin Pathol, 1996; 105: 149-56
4. Hodge AM, de Courten MP, Zimmet P. Obesity and type 2 diabetes mellitus. In: Björntorp P, editor. The International Textbook of Obesity. Chichester: John Wiley & Sons; 2001. p. 351-364
5. Chalew S, Nagel H, Shore S. The hypothalamic-pituitary-adrenal axis in obesity. Obes Res, 1995; 3: 371-82
6. Björntorp P, Rosmond R. Obesity and cortisol. Nutrition, 2000; 16: 924-936
7. Rosmond R, Björntorp P. New targets for the clinical assessment of salivary cortisol secretion. J Endocrinol Invest, 2001; 24: 639-41
8. Clements AD, Parker CR. The relationship between salivary cortisol concentrations in frozen versus mailed samples. Psychoneuroendocrinology, 1998; 23: 613-6
9. Aardal-Eriksson E, Karlberg BE, Holm AC: Salivary cortisol - an alternative to serum cortisol determinations in dynamic function tests. Clin Chem Lab Med, 1998; 36: 215-22
10. Castro M, Elias PC, Quidute AR et al: Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab, 1999; 84: 878-82.
11. Findling JW, Raff H: Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am, 1999; 28: 191-210
12. Rosmond R, Dallman MF, Björntorp P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab, 1998; 83: 1853-9
13. Rosmond R. Björntorp P: Blood pressure in relation to obesity, insulin and the hypothalamic- pituitary-adrenal axis in Swedish men. J Hypertens, 1998; 16: 1721-6
14. Rosmond R, Holm G, Björntorp P: Food-induced cortisol secretion in relation to anthropometric, metabolic and haemodynamic variables in men. Int J Obes Relat Metab Disord, 2000; 24: 416-22
15. Rosmond R, Björntorp P: Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity. Metabolism, 1998; 47: 1187-93
16. Bartels M, Van den Berg M, Sluyter F et al: Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology, 2003; 28: 121-37
17. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med, 1998; 338: 171-9
18. McEwen BS: Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. Metabolism, 2002; 51: 2-4
19. Chrousos GP: Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci, 1998; 851: 311-35
20. Björntorp P, Rosmond R: Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci, 1999; 892: 297-307
21. Rosmond R: Visceral obesity and the metabolic syndrome. In: Björntorp P, editor. The International Textbook of Obesity. Chichester: John Wiley & Sons, 2001; 339-350
22. Rosmond R, Björntorp P: Occupational status, cortisol secretory pattern, and visceral obesity in middle-aged men. Obes Res, 2000; 8: 445-50
23. Jayo JM, Shively CA, Kaplan JR, Manuck SB: Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Int J Obes Relat Metab Disord, 1993; 17: 597-604
24. Shively CA, Laber-Laird K, Anton RF: Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry, 1997; 41: 871-82
25. Rosmond R: The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res, 2002; 10: 1078-86
26. Fernandez-Real JM, Gutierrez C, Ricart W et al. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes, 1997; 46: 1468-72
27. Rosmond R, Chagnon M, Bouchard C, Björntorp P: G-308A polymorphism of the tumor necrosis factor alpha gene promoter and salivary cortisol secretion. J Clin Endocrinol Metab, 2001; 86: 2178-80
28. Lönn L, Kvist H, Ernest I, Sjöström L: Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism, 1994; 43: 1517-22
29. Arvaniti K, Richard D, Picard F, Deshaies Y: Lipid deposition in rats centrally infused with leptin in the presence or absence of corticosterone. Am J Physiol Endocrinol Metab, 2001; 281: E809-16
30. Björntorp P: Metabolic implications of body fat distribution. Diabetes Care, 1991; 14: 1132-43
31. Amatruda JM, Livingston JN, Lockwood DH: Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev, 1985; 1: 293-317
32. Lambillotte C, Gilon P, Henquin JC: Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest, 1997; 99: 414-23
33. Garvey WT, Huecksteadt TP, Monzon R, Marshall S: Dexamethasone regulates the glucose transport system in primary cultured adipocytes: different mechanisms of insulin resistance after acute and chronic exposure. Endocrinology, 1989; 124: 2063-73
34. Coderre L, Vallega GA, Pilch PF, Chipkin SR: In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol, 1996; 271: 643-8
35. Pagano G, Cavallo-Perin P, Cassader M et al: An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy suhjects. J Clin Invest, 1983; 72: 1814-20
36. Wajngot A, Khan A, Giacca A et al: Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects. Am J Physiol, 1990; 259: 626-32
37. Dallman MF, Strack AM, Akana SF et al: Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol, 1993; 14: 303-47
38. Holmäng A, Björntorp P: The effects of cortisol on insulin sensitivity in muscle. Acta Physiol Scand, 1992; 144: 425-31
39. Reynolds RM, Chapman KE, Seckl JR et al: Skeletal muscle glucocorticoid receptor density and insulin resistance. JAMA, 2002; 287: 2505-6